Ascent Biomedical Ventures (operating via ABV, LLC) is a New York, New York–based venture capital firm founded in 2004 that specializes in seed and early-stage investments in biomedical technology companies, with a focus on medical devices, therapeutics, biotechnology and related health-care innovation sectors; it manages institutional capital and strategic support for portfolio companies in the United States and works with scientific founders to advance translational research into commercial products.